Gene · 9939
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Congenital limb deficiency: Genetic investigation of 44 individuals presenting mainly longitudinal defects in isolated or syndromic forms. | Clin Genet | 2021 | 34341987 | PubTator, text mining | PubMed |
| Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper. | BMJ Open | 2021 | 34341043 | PubTator, text mining | PubMed |
| A Comprehensive Pan-Cancer Analysis of RBM8A Based on Data Mining. | J Oncol | 2021 | 34326876 | PubTator, text mining | PubMed |
| [Genetic Study and Prenatal Diagnosis of a Family with Thrombocytopenia-Absent Radius (TAR) Syndrome]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2021 | 34323054 | PubTator, text mining | PubMed |
| Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma. | Int J Mol Sci | 2021 | 34299096 | PubTator, text mining | PubMed |
| m6A mRNA Methylation Regulates Epithelial Innate Antimicrobial Defense Against Cryptosporidial Infection. | Front Immunol | 2021 | 34295340 | PubTator, text mining | PubMed |
| Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy. | Cell Rep | 2021 | 34270918 | PubTator, text mining | PubMed |
| Peganum spp.: A Comprehensive Review on Bioactivities and Health-Enhancing Effects and Their Potential for the Formulation of Functional Foods and Pharmaceutical Drugs. | Oxid Med Cell Longev | 2021 | 34257813 | PubTator, text mining | PubMed |
| Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy. | Front Genet | 2021 | 34249098 | PubTator, text mining | PubMed |
| Application of high-throughput sequencing for hereditary thrombocytopenia in southwestern China. | J Clin Lab Anal | 2021 | 34237177 | PubTator, text mining | PubMed |
| Alteration of protein expression and spliceosome pathway activity during Barrett's carcinogenesis. | J Gastroenterol | 2021 | 34227026 | PubTator, text mining | PubMed |
| Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations. | Cancer Res | 2021 | 34215620 | PubTator, text mining | PubMed |
| Role and Perspective of Molecular Simulation-Based Investigation of RNA-Ligand Interaction: From Small Molecules and Peptides to Photoswitchable RNA Binding. | Molecules | 2021 | 34205049 | PubTator, text mining | PubMed |
| The Exon Junction Complex Core Represses Cancer-Specific Mature mRNA Re-splicing: A Potential Key Role in Terminating Splicing. | Int J Mol Sci | 2021 | 34204574 | PubTator, text mining | PubMed |
| The Identification of RNA-Binding Proteins Functionally Associated with Tumor Progression in Gastrointestinal Cancer. | Cancers (Basel) | 2021 | 34202873 | PubTator, text mining | PubMed |
| Manipulation of Cellular Processes via Nucleolus Hijaking in the Course of Viral Infection in Mammals. | Cells | 2021 | 34202380 | PubTator, text mining | PubMed |
| Synergistic Chromatin-Modifying Treatments Reactivate Latent HIV and Decrease Migration of Multiple Host-Cell Types. | Viruses | 2021 | 34201394 | PubTator, text mining | PubMed |
| How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System. | Cells | 2021 | 34200500 | PubTator, text mining | PubMed |
| Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome. | Cell Rep | 2021 | 34192540 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9939/papers?page=22